> top > docs > PubMed:18439803 > annotations

PubMed:18439803 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 121-125 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114
T4 511-515 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-126 Sentence denotes Acute effects of N-(2-propylpentanoyl)urea on hippocampal amino acid neurotransmitters in pilocarpine-induced seizure in rats.
T2 127-408 Sentence denotes The present study aimed to investigate the anticonvulsant activity as well as the effects on the level of hippocampal amino acid neurotransmitters (glutamate, aspartate, glycine and GABA) of N-(2-propylpentanoyl)urea (VPU) in comparison to its parent compound, valproic acid (VPA).
T3 409-606 Sentence denotes VPU was more potent than VPA, exhibiting the median effective dose (ED(50)) of 49 mg/kg in protecting rats against pilocarpine-induced seizure whereas the corresponding value for VPA was 322 mg/kg.
T4 607-842 Sentence denotes In vivo microdialysis demonstrated that an intraperitoneal administration of pilocarpine induced a pronounced increment of hippocampal glutamate and aspartate whereas no significant change was observed on the level of glycine and GABA.
T5 843-1009 Sentence denotes Pretreatment with either VPU (50 and 100 mg/kg) or VPA (300 and 600 mg/kg) completely abolished pilocarpine-evoked increases in extracellular glutamate and aspartate.
T6 1010-1179 Sentence denotes In addition, a statistically significant reduction was also observed on the level of GABA and glycine but less than a drastic reduction of glutamate and aspartate level.
T7 1180-1446 Sentence denotes Based on the finding that VPU and VPA could protect the animals against pilocarpine-induced seizure it is suggested that the reduction of inhibitory amino acid neurotransmitters was comparatively minor and offset by a pronounced reduction of glutamate and aspartate.
T8 1447-1700 Sentence denotes Therefore, like VPA, the finding that VPU could drastically reduce pilocarpine-induced increases in glutamate and aspartate should account, at least partly, for its anticonvulsant activity observed in pilocarpine-induced seizure in experimental animals.
T9 1701-1786 Sentence denotes Some other mechanism than those being reported herein should be further investigated.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
4964 17-42 ChemicalEntity denotes N-(2-propylpentanoyl)urea MESH:C108761
4965 90-101 ChemicalEntity denotes pilocarpine MESH:D010862
4966 110-117 DiseaseOrPhenotypicFeature denotes seizure MESH:D012640
4967 121-125 OrganismTaxon denotes rats NCBITaxon:10116
4968 275-284 ChemicalEntity denotes glutamate MESH:D018698
4969 286-295 ChemicalEntity denotes aspartate MESH:D001224
4970 297-304 ChemicalEntity denotes glycine MESH:D005998
4971 309-313 ChemicalEntity denotes GABA MESH:D005680
4972 318-343 ChemicalEntity denotes N-(2-propylpentanoyl)urea MESH:C108761
4973 345-348 ChemicalEntity denotes VPU MESH:C108761
4974 388-401 ChemicalEntity denotes valproic acid MESH:D014635
4975 403-406 ChemicalEntity denotes VPA MESH:D014635
4976 409-412 ChemicalEntity denotes VPU MESH:C108761
4977 434-437 ChemicalEntity denotes VPA MESH:D014635
4978 511-515 OrganismTaxon denotes rats NCBITaxon:10116
4979 524-535 ChemicalEntity denotes pilocarpine MESH:D010862
4980 544-551 DiseaseOrPhenotypicFeature denotes seizure MESH:D012640
4981 588-591 ChemicalEntity denotes VPA MESH:D014635
4982 684-695 ChemicalEntity denotes pilocarpine MESH:D010862
4983 742-751 ChemicalEntity denotes glutamate MESH:D018698
4984 756-765 ChemicalEntity denotes aspartate MESH:D001224
4985 825-832 ChemicalEntity denotes glycine MESH:D005998
4986 837-841 ChemicalEntity denotes GABA MESH:D005680
4987 868-871 ChemicalEntity denotes VPU MESH:C108761
4988 894-897 ChemicalEntity denotes VPA MESH:D014635
4989 939-950 ChemicalEntity denotes pilocarpine MESH:D010862
4990 985-994 ChemicalEntity denotes glutamate MESH:D018698
4991 999-1008 ChemicalEntity denotes aspartate MESH:D001224
4992 1095-1099 ChemicalEntity denotes GABA MESH:D005680
4993 1104-1111 ChemicalEntity denotes glycine MESH:D005998
4994 1149-1158 ChemicalEntity denotes glutamate MESH:D018698
4995 1163-1172 ChemicalEntity denotes aspartate MESH:D001224
4996 1206-1209 ChemicalEntity denotes VPU MESH:C108761
4997 1214-1217 ChemicalEntity denotes VPA MESH:D014635
4998 1252-1263 ChemicalEntity denotes pilocarpine MESH:D010862
4999 1272-1279 DiseaseOrPhenotypicFeature denotes seizure MESH:D012640
5000 1422-1431 ChemicalEntity denotes glutamate MESH:D018698
5001 1436-1445 ChemicalEntity denotes aspartate MESH:D001224
5002 1463-1466 ChemicalEntity denotes VPA MESH:D014635
5003 1485-1488 ChemicalEntity denotes VPU MESH:C108761
5004 1514-1525 ChemicalEntity denotes pilocarpine MESH:D010862
5005 1547-1556 ChemicalEntity denotes glutamate MESH:D018698
5006 1561-1570 ChemicalEntity denotes aspartate MESH:D001224
5007 1648-1659 ChemicalEntity denotes pilocarpine MESH:D010862
5008 1668-1675 DiseaseOrPhenotypicFeature denotes seizure MESH:D012640

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 918-928 DiseaseOrPhenotypicFeature denotes completely 0700063

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 58-68 GeneOrGeneProduct denotes amino acid
T2 110-117 GeneOrGeneProduct denotes seizure
T3 245-255 GeneOrGeneProduct denotes amino acid
T4 275-284 GeneOrGeneProduct denotes glutamate
T5 286-295 GeneOrGeneProduct denotes aspartate
T6 309-313 GeneOrGeneProduct denotes GABA
T7 397-401 GeneOrGeneProduct denotes acid
T8 544-551 GeneOrGeneProduct denotes seizure
T9 742-751 GeneOrGeneProduct denotes glutamate
T10 756-765 GeneOrGeneProduct denotes aspartate
T11 837-841 GeneOrGeneProduct denotes GABA
T12 971-984 GeneOrGeneProduct denotes extracellular
T13 985-994 GeneOrGeneProduct denotes glutamate
T14 999-1008 GeneOrGeneProduct denotes aspartate
T15 1095-1099 GeneOrGeneProduct denotes GABA
T16 1149-1158 GeneOrGeneProduct denotes glutamate
T17 1163-1172 GeneOrGeneProduct denotes aspartate
T18 1272-1279 GeneOrGeneProduct denotes seizure
T19 1329-1339 GeneOrGeneProduct denotes amino acid
T20 1376-1381 GeneOrGeneProduct denotes minor
T21 1422-1431 GeneOrGeneProduct denotes glutamate
T22 1436-1445 GeneOrGeneProduct denotes aspartate
T23 1458-1462 GeneOrGeneProduct denotes like
T24 1547-1556 GeneOrGeneProduct denotes glutamate
T25 1561-1570 GeneOrGeneProduct denotes aspartate
T26 1668-1675 GeneOrGeneProduct denotes seizure
T27 1706-1711 GeneOrGeneProduct denotes other

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 38-42 GeneOrGeneProduct denotes urea
T2 58-68 GeneOrGeneProduct denotes amino acid
T3 102-109 GeneOrGeneProduct denotes induced
T4 110-117 GeneOrGeneProduct denotes seizure
T5 185-193 GeneOrGeneProduct denotes activity
T6 245-255 GeneOrGeneProduct denotes amino acid
T7 275-284 GeneOrGeneProduct denotes glutamate
T8 286-295 GeneOrGeneProduct denotes aspartate
T9 309-313 GeneOrGeneProduct denotes GABA
T10 339-343 GeneOrGeneProduct denotes urea
T11 397-401 GeneOrGeneProduct denotes acid
T12 491-493 GeneOrGeneProduct denotes mg
T13 536-543 GeneOrGeneProduct denotes induced
T14 544-551 GeneOrGeneProduct denotes seizure
T15 578-583 GeneOrGeneProduct denotes value
T16 600-602 GeneOrGeneProduct denotes mg
T17 696-703 GeneOrGeneProduct denotes induced
T18 742-751 GeneOrGeneProduct denotes glutamate
T19 756-765 GeneOrGeneProduct denotes aspartate
T20 837-841 GeneOrGeneProduct denotes GABA
T21 884-886 GeneOrGeneProduct denotes mg
T22 911-913 GeneOrGeneProduct denotes mg
T23 971-984 GeneOrGeneProduct denotes extracellular
T24 985-994 GeneOrGeneProduct denotes glutamate
T25 999-1008 GeneOrGeneProduct denotes aspartate
T26 1095-1099 GeneOrGeneProduct denotes GABA
T27 1149-1158 GeneOrGeneProduct denotes glutamate
T28 1163-1172 GeneOrGeneProduct denotes aspartate
T29 1180-1185 GeneOrGeneProduct denotes Based
T30 1193-1200 GeneOrGeneProduct denotes finding
T31 1264-1271 GeneOrGeneProduct denotes induced
T32 1272-1279 GeneOrGeneProduct denotes seizure
T33 1329-1339 GeneOrGeneProduct denotes amino acid
T34 1376-1381 GeneOrGeneProduct denotes minor
T35 1422-1431 GeneOrGeneProduct denotes glutamate
T36 1436-1445 GeneOrGeneProduct denotes aspartate
T37 1458-1462 GeneOrGeneProduct denotes like
T38 1472-1479 GeneOrGeneProduct denotes finding
T39 1507-1513 GeneOrGeneProduct denotes reduce
T40 1526-1533 GeneOrGeneProduct denotes induced
T41 1547-1556 GeneOrGeneProduct denotes glutamate
T42 1561-1570 GeneOrGeneProduct denotes aspartate
T43 1596-1602 GeneOrGeneProduct denotes partly
T44 1627-1635 GeneOrGeneProduct denotes activity
T45 1660-1667 GeneOrGeneProduct denotes induced
T46 1668-1675 GeneOrGeneProduct denotes seizure
T47 1706-1711 GeneOrGeneProduct denotes other

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 110-117 DiseaseOrPhenotypicFeature denotes seizure D012640
T2 544-551 DiseaseOrPhenotypicFeature denotes seizure D012640
T3 1272-1279 DiseaseOrPhenotypicFeature denotes seizure D012640
T4 1668-1675 DiseaseOrPhenotypicFeature denotes seizure D012640

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 275-284 GeneOrGeneProduct denotes glutamate
T2 742-751 GeneOrGeneProduct denotes glutamate
T3 985-994 GeneOrGeneProduct denotes glutamate
T4 1149-1158 GeneOrGeneProduct denotes glutamate
T5 1422-1431 GeneOrGeneProduct denotes glutamate
T6 1547-1556 GeneOrGeneProduct denotes glutamate

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 121-125 OrganismTaxon denotes rats
T2 511-515 OrganismTaxon denotes rats

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 110-117 DiseaseOrPhenotypicFeature denotes seizure D012640
T2 544-551 DiseaseOrPhenotypicFeature denotes seizure D012640
T3 1272-1279 DiseaseOrPhenotypicFeature denotes seizure D012640
T4 1668-1675 DiseaseOrPhenotypicFeature denotes seizure D012640

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 110-117 DiseaseOrPhenotypicFeature denotes seizure D012640
T2 544-551 DiseaseOrPhenotypicFeature denotes seizure D012640
T3 1272-1279 DiseaseOrPhenotypicFeature denotes seizure D012640
T4 1668-1675 DiseaseOrPhenotypicFeature denotes seizure D012640

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 17-42 ChemicalEntity denotes N-(2-propylpentanoyl)urea C108761|ChemicalEntity
T3 69-86 ChemicalEntity denotes neurotransmitters ChemicalEntity
T4 90-101 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462
T6 256-273 ChemicalEntity denotes neurotransmitters ChemicalEntity
T7 275-284 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_29987|http://purl.obolibrary.org/obo/CHEBI_14321
T9 286-295 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_72314|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_132943
T12 297-304 ChemicalEntity denotes glycine http://purl.obolibrary.org/obo/CHEBI_57305|http://purl.obolibrary.org/obo/CHEBI_29947|http://purl.obolibrary.org/obo/CHEBI_15428
T15 309-313 ChemicalEntity denotes GABA http://purl.obolibrary.org/obo/CHEBI_16865
T16 318-343 ChemicalEntity denotes N-(2-propylpentanoyl)urea C108761|ChemicalEntity
T18 345-348 ChemicalEntity denotes VPU ChemicalEntity
T19 388-401 ChemicalEntity denotes valproic acid D014635|http://purl.obolibrary.org/obo/CHEBI_39867
T21 403-406 ChemicalEntity denotes VPA http://purl.obolibrary.org/obo/CHEBI_39867|D014635
T23 409-412 ChemicalEntity denotes VPU ChemicalEntity
T24 434-437 ChemicalEntity denotes VPA http://purl.obolibrary.org/obo/CHEBI_39867|D014635
T26 524-535 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462
T28 588-591 ChemicalEntity denotes VPA http://purl.obolibrary.org/obo/CHEBI_39867|D014635
T30 684-695 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462
T32 742-751 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_29987|http://purl.obolibrary.org/obo/CHEBI_14321
T34 756-765 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_72314|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_132943
T37 825-832 ChemicalEntity denotes glycine http://purl.obolibrary.org/obo/CHEBI_57305|http://purl.obolibrary.org/obo/CHEBI_29947|http://purl.obolibrary.org/obo/CHEBI_15428
T40 837-841 ChemicalEntity denotes GABA http://purl.obolibrary.org/obo/CHEBI_16865
T41 868-871 ChemicalEntity denotes VPU ChemicalEntity
T42 894-897 ChemicalEntity denotes VPA http://purl.obolibrary.org/obo/CHEBI_39867|D014635
T44 939-950 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462
T46 985-994 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_29987|http://purl.obolibrary.org/obo/CHEBI_14321
T48 999-1008 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_72314|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_132943
T51 1095-1099 ChemicalEntity denotes GABA http://purl.obolibrary.org/obo/CHEBI_16865
T52 1104-1111 ChemicalEntity denotes glycine http://purl.obolibrary.org/obo/CHEBI_57305|http://purl.obolibrary.org/obo/CHEBI_29947|http://purl.obolibrary.org/obo/CHEBI_15428
T55 1149-1158 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_29987|http://purl.obolibrary.org/obo/CHEBI_14321
T57 1163-1172 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_72314|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_132943
T60 1206-1209 ChemicalEntity denotes VPU ChemicalEntity
T61 1214-1217 ChemicalEntity denotes VPA http://purl.obolibrary.org/obo/CHEBI_39867|D014635
T63 1252-1263 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462
T65 1340-1357 ChemicalEntity denotes neurotransmitters ChemicalEntity
T66 1422-1431 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_29987|http://purl.obolibrary.org/obo/CHEBI_14321
T68 1436-1445 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_72314|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_132943
T71 1463-1466 ChemicalEntity denotes VPA http://purl.obolibrary.org/obo/CHEBI_39867|D014635
T73 1485-1488 ChemicalEntity denotes VPU ChemicalEntity
T74 1514-1525 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462
T76 1547-1556 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_29987|http://purl.obolibrary.org/obo/CHEBI_14321
T78 1561-1570 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_72314|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_132943
T81 1648-1659 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T81 1648-1659 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T78 1561-1570 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314
T76 1547-1556 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_14321|http://purl.obolibrary.org/obo/CHEBI_29987
T74 1514-1525 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T73 1485-1488 ChemicalEntity denotes VPU ChemicalEntity
T71 1463-1466 ChemicalEntity denotes VPA D014635|http://purl.obolibrary.org/obo/CHEBI_39867
T68 1436-1445 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314
T66 1422-1431 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_14321|http://purl.obolibrary.org/obo/CHEBI_29987
T65 1340-1357 ChemicalEntity denotes neurotransmitters ChemicalEntity
T63 1252-1263 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T61 1214-1217 ChemicalEntity denotes VPA D014635|http://purl.obolibrary.org/obo/CHEBI_39867
T60 1206-1209 ChemicalEntity denotes VPU ChemicalEntity
T57 1163-1172 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314
T55 1149-1158 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_14321|http://purl.obolibrary.org/obo/CHEBI_29987
T52 1104-1111 ChemicalEntity denotes glycine http://purl.obolibrary.org/obo/CHEBI_15428|http://purl.obolibrary.org/obo/CHEBI_29947|http://purl.obolibrary.org/obo/CHEBI_57305
T51 1095-1099 ChemicalEntity denotes GABA http://purl.obolibrary.org/obo/CHEBI_16865
T48 999-1008 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314|http://purl.obolibrary.org/obo/CHEBI_132943
T46 985-994 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_14321|http://purl.obolibrary.org/obo/CHEBI_29987
T44 939-950 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T42 894-897 ChemicalEntity denotes VPA D014635|http://purl.obolibrary.org/obo/CHEBI_39867
T41 868-871 ChemicalEntity denotes VPU ChemicalEntity
T40 837-841 ChemicalEntity denotes GABA http://purl.obolibrary.org/obo/CHEBI_16865
T37 825-832 ChemicalEntity denotes glycine http://purl.obolibrary.org/obo/CHEBI_15428|http://purl.obolibrary.org/obo/CHEBI_29947|http://purl.obolibrary.org/obo/CHEBI_57305
T34 756-765 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314
T32 742-751 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_14321|http://purl.obolibrary.org/obo/CHEBI_29987
T30 684-695 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T28 588-591 ChemicalEntity denotes VPA D014635|http://purl.obolibrary.org/obo/CHEBI_39867
T26 524-535 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T24 434-437 ChemicalEntity denotes VPA D014635|http://purl.obolibrary.org/obo/CHEBI_39867
T23 409-412 ChemicalEntity denotes VPU ChemicalEntity
T21 403-406 ChemicalEntity denotes VPA D014635|http://purl.obolibrary.org/obo/CHEBI_39867
T19 388-401 ChemicalEntity denotes valproic acid http://purl.obolibrary.org/obo/CHEBI_39867|D014635
T18 345-348 ChemicalEntity denotes VPU ChemicalEntity
T16 318-343 ChemicalEntity denotes N-(2-propylpentanoyl)urea ChemicalEntity|C108761
T15 309-313 ChemicalEntity denotes GABA http://purl.obolibrary.org/obo/CHEBI_16865
T12 297-304 ChemicalEntity denotes glycine http://purl.obolibrary.org/obo/CHEBI_15428|http://purl.obolibrary.org/obo/CHEBI_29947|http://purl.obolibrary.org/obo/CHEBI_57305
T9 286-295 ChemicalEntity denotes aspartate http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314
T7 275-284 ChemicalEntity denotes glutamate http://purl.obolibrary.org/obo/CHEBI_14321|http://purl.obolibrary.org/obo/CHEBI_29987
T6 256-273 ChemicalEntity denotes neurotransmitters ChemicalEntity
T4 90-101 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T3 69-86 ChemicalEntity denotes neurotransmitters ChemicalEntity
T1 17-42 ChemicalEntity denotes N-(2-propylpentanoyl)urea ChemicalEntity|C108761
T55835 1547-1556 GeneOrGeneProduct denotes glutamate
T5 1422-1431 GeneOrGeneProduct denotes glutamate
T21509 1149-1158 GeneOrGeneProduct denotes glutamate
T58501 985-994 GeneOrGeneProduct denotes glutamate
T2 742-751 GeneOrGeneProduct denotes glutamate
T23969 275-284 GeneOrGeneProduct denotes glutamate
T55089 1668-1675 DiseaseOrPhenotypicFeature denotes seizure D012640
T52311 1272-1279 DiseaseOrPhenotypicFeature denotes seizure D012640
T29449 544-551 DiseaseOrPhenotypicFeature denotes seizure D012640
T41848 110-117 DiseaseOrPhenotypicFeature denotes seizure D012640
T35093 511-515 OrganismTaxon denotes rats
T87767 121-125 OrganismTaxon denotes rats